FDA Fast Tracks Potential CAR T-Cell Therapy for Lupus FDA Fast Tracks Potential CAR T-Cell Therapy for Lupus

The cellular therapy depletes CD19-positive B cells with the goal of ' resetting ' the immune system to achieve durable remission.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news